Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-173

  1. 16,284 Posts.
    lightbulb Created with Sketch. 6185
    Glad he holds Dr Krause in high regard because he doesn’t look to be a big fan of the AA pathway for ‘certain medicines’ …. wonder what those certain medicines are ? Thankfully Mesoblast have extensive trial data for CHF and a meeting already scheduled

    GLTAH

    https://edition.cnn.com/2025/05/06/health/fda-vinay-prasad-vaccines

    FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division


    Biotech stocks tumbled more than 5% in the hours after the announcement as industry analysts called Prasad an “anti-establishment” choice and noted that he has also questioned the FDA’s use of accelerated approval processes for certain medicines.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.86
Change
0.065(3.62%)
Mkt cap ! $2.376B
Open High Low Value Volume
$1.83 $1.89 $1.83 $8.165M 4.404M

Buyers (Bids)

No. Vol. Price($)
2 6744 $1.86
 

Sellers (Offers)

Price($) Vol. No.
$1.86 5904 3
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.